Company Filing History:
Years Active: 2019
Title: Genta Nagae: Innovator in Lung Cancer Detection
Introduction
Genta Nagae is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the detection of lung cancer. His innovative work has led to the development of a unique determination device that aids in the analysis of genetic markers associated with lung cancer.
Latest Patents
Genta Nagae holds a patent for a determination device, computer readable medium, and marker for obtaining information on lung cancer. This device enables a computer to analyze the methylation status of specific CpG sites in the promoter regions of genes such as HOXB4 and ZSCAN31. The analysis results in a determination that provides crucial information regarding lung cancer in subjects based on their DNA samples.
Career Highlights
Throughout his career, Genta Nagae has worked with prominent organizations, including Sysmex Corporation and The University of Tokyo. His experience in these institutions has allowed him to refine his expertise in medical technology and innovation.
Collaborations
Genta Nagae has collaborated with notable colleagues such as Kaya Tai and Hiroyuki Aburatani. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Genta Nagae's contributions to lung cancer detection through his innovative patent highlight his role as a significant inventor in the medical field. His work continues to impact the way lung cancer is diagnosed and treated, showcasing the importance of innovation in healthcare.